272 related articles for article (PubMed ID: 17964614)
1. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control.
Lodovici M; Giovannelli L; Pitozzi V; Bigagli E; Bardini G; Rotella CM
Mutat Res; 2008 Feb; 638(1-2):98-102. PubMed ID: 17964614
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA oxidation and manganese superoxide dismutase activity in peripheral blood mononuclear cells from type 2 diabetic patients.
García-Ramírez M; Francisco G; García-Arumí E; Hernández C; Martínez R; Andreu AL; Simó R
Diabetes Metab; 2008 Apr; 34(2):117-24. PubMed ID: 18291700
[TBL] [Abstract][Full Text] [Related]
4. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients.
Komosińska-Vassev K; Olczyk K; Olczyk P; Winsz-Szczotka K
Diabetes Res Clin Pract; 2005 Jun; 68(3):207-16. PubMed ID: 15936462
[TBL] [Abstract][Full Text] [Related]
5. Increased oxidative damage with altered antioxidative status in type 2 diabetic patients harboring the 16189 T to C variant of mitochondrial DNA.
Lin TK; Chen SD; Wang PW; Wei YH; Lee CF; Chen TL; Chuang YC; Tan TY; Chang KC; Liou CW
Ann N Y Acad Sci; 2005 May; 1042():64-9. PubMed ID: 15965046
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes.
Firoozrai M; Nourbakhsh M; Razzaghy-Azar M
Diabetes Res Clin Pract; 2007 Sep; 77(3):427-32. PubMed ID: 17360068
[TBL] [Abstract][Full Text] [Related]
8. Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension.
Skalska AB; Pietrzycka A; Stepniewski M
Clin Biochem; 2009 Mar; 42(4-5):358-64. PubMed ID: 19046960
[TBL] [Abstract][Full Text] [Related]
9. In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM).
Sliwinska A; Blasiak J; Kasznicki J; Drzewoski J
Chem Biol Interact; 2008 Jun; 173(3):159-65. PubMed ID: 18485337
[TBL] [Abstract][Full Text] [Related]
10. Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status.
Van Campenhout A; Van Campenhout C; Lagrou AR; Abrams P; Moorkens G; Van Gaal L; Manuel-y-Keenoy B
Diabetes Metab Res Rev; 2006; 22(6):444-54. PubMed ID: 16506275
[TBL] [Abstract][Full Text] [Related]
11. Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy.
Adaikalakoteswari A; Rema M; Mohan V; Balasubramanyam M
Int J Biochem Cell Biol; 2007; 39(9):1673-84. PubMed ID: 17540609
[TBL] [Abstract][Full Text] [Related]
12. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy.
Pan HZ; Zhang H; Chang D; Li H; Sui H
Br J Ophthalmol; 2008 Apr; 92(4):548-51. PubMed ID: 18369071
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients.
Manfredini V; Biancini GB; Vanzin CS; Dal Vesco AM; Cipriani F; Biasi L; Treméa R; Deon M; Peralba Mdo C; Wajner M; Vargas CR
Cell Biochem Funct; 2010 Jul; 28(5):360-6. PubMed ID: 20589733
[TBL] [Abstract][Full Text] [Related]
14. The relationship between levels of alpha1-acid glycoprotein and metabolic parameters of diabetes mellitus.
Akbay E; Yetkin I; Ersoy R; Kulaksizoğlu S; Törüner F; Arslan M
Diabetes Nutr Metab; 2004 Dec; 17(6):331-5. PubMed ID: 15887626
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus.
Peerapatdit T; Likidlilid A; Patchanans N; Somkasetrin A
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S141-6. PubMed ID: 17718255
[TBL] [Abstract][Full Text] [Related]
16. Oxidizing and reducing responses in type 1 diabetic patients determined up to 5 years after the clinical onset of the disease.
Reis JS; Bosco AA; Veloso CA; Mattos RT; Purish S; Nogueira-Machado JA
Acta Diabetol; 2008 Dec; 45(4):221-4. PubMed ID: 18649042
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
Dave GS; Kalia K
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
[TBL] [Abstract][Full Text] [Related]
18. [The total antioxidant capacity and low-molecular antioxidant concentration in plasma of type-2 diabetes patients with different stage of metabolic compensation and concomitant diabetic nephropathy].
Błaszczak R; Kujawski K; Kedziora-Kornatowska K; Kornatowski T; Kedziora J; Szadujkis-Szadurski L; Markuszewski L; Rysz J; Ertel D; Olszewski R
Pol Merkur Lekarski; 2005 Jan; 18(103):29-32. PubMed ID: 15859542
[TBL] [Abstract][Full Text] [Related]
19. DNA damage and repair in type 2 diabetes mellitus.
Blasiak J; Arabski M; Krupa R; Wozniak K; Zadrozny M; Kasznicki J; Zurawska M; Drzewoski J
Mutat Res; 2004 Oct; 554(1-2):297-304. PubMed ID: 15450427
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ROS production in peripheral blood mononuclear cells from type 2 diabetic patients by autologous plasma depends on Akt/PKB signaling pathway.
Veloso CA; Isoni CA; Borges EA; Mattos RT; Calsolari MR; Reis JS; Bosco AA; Chaves MM; Nogueira-Machado JA
Clin Chim Acta; 2008 Aug; 394(1-2):77-80. PubMed ID: 18455998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
